標(biāo)題: Titlebook: Drug Resistance in Cancer: Mechanisms and Strategies; Sameer Ullah Khan,Fayaz Malik Book 2024 The Editor(s) (if applicable) and The Author [打印本頁(yè)] 作者: 添加劑 時(shí)間: 2025-3-21 19:57
書(shū)目名稱(chēng)Drug Resistance in Cancer: Mechanisms and Strategies影響因子(影響力)
書(shū)目名稱(chēng)Drug Resistance in Cancer: Mechanisms and Strategies影響因子(影響力)學(xué)科排名
書(shū)目名稱(chēng)Drug Resistance in Cancer: Mechanisms and Strategies網(wǎng)絡(luò)公開(kāi)度
書(shū)目名稱(chēng)Drug Resistance in Cancer: Mechanisms and Strategies網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書(shū)目名稱(chēng)Drug Resistance in Cancer: Mechanisms and Strategies被引頻次
書(shū)目名稱(chēng)Drug Resistance in Cancer: Mechanisms and Strategies被引頻次學(xué)科排名
書(shū)目名稱(chēng)Drug Resistance in Cancer: Mechanisms and Strategies年度引用
書(shū)目名稱(chēng)Drug Resistance in Cancer: Mechanisms and Strategies年度引用學(xué)科排名
書(shū)目名稱(chēng)Drug Resistance in Cancer: Mechanisms and Strategies讀者反饋
書(shū)目名稱(chēng)Drug Resistance in Cancer: Mechanisms and Strategies讀者反饋學(xué)科排名
作者: 相一致 時(shí)間: 2025-3-21 20:14
Notwendige Bestandteile von BBS,urvival. This chapter provides an overview of current cancer therapies, encompassing radiation therapy, chemotherapy, targeted therapy, immunotherapy, and emerging therapeutic modalities such as viral and gene therapy. This chapter explores the intricate molecular mechanisms underpinning resistance 作者: superfluous 時(shí)間: 2025-3-22 01:00 作者: 積習(xí)已深 時(shí)間: 2025-3-22 08:13
Das Gerichtskostengesetz (GKG),onment (TME), encompassing B cells, effector and regulatory T cells, tumor-associated macrophages (TAMs), myeloid-derived suppressor cells (MDSCs), and tumor-associated neutrophils (TANs), plays a decisive role in tumorigenesis. Various studies showed that MDSCs can create immunosuppressive microenv作者: parsimony 時(shí)間: 2025-3-22 10:18 作者: Hla461 時(shí)間: 2025-3-22 12:54 作者: Hla461 時(shí)間: 2025-3-22 17:59 作者: mastopexy 時(shí)間: 2025-3-23 00:28
Gewalt gegen die Afroamerikaner synthesis, energy production, and waste disposal. The intricate organization of these compartments creates distinct microenvironments that impact cellular responses to external stimuli, including drug exposure. Understanding the interplay between intracellular compartments and drug resistance is cr作者: 商店街 時(shí)間: 2025-3-23 03:43 作者: Cirrhosis 時(shí)間: 2025-3-23 06:39 作者: Popcorn 時(shí)間: 2025-3-23 10:20 作者: fiction 時(shí)間: 2025-3-23 14:41
https://doi.org/10.1007/978-981-97-1666-1Cancer drug resistance; Mechanisms of resistance; Cancer stem cells; Tumor microenvironment; Novel strat作者: Fantasy 時(shí)間: 2025-3-23 21:56
978-981-97-1668-5The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Singapor作者: 騷動(dòng) 時(shí)間: 2025-3-24 01:55
Sameer Ullah Khan,Fayaz MalikExplores various mechanisms and players involved in cancer drug resistance.Offers insights into immune cells and tumor microenvironment‘s role in cancer drug resistance.Provides strategies and future 作者: PET-scan 時(shí)間: 2025-3-24 05:27
http://image.papertrans.cn/e/image/283120.jpg作者: 合同 時(shí)間: 2025-3-24 09:34
https://doi.org/10.34157/978-3-648-16940-7g drugs, novel strategic options with better efficacy need to be explored that overcome resistance. Combination therapy is a widely used alternative with a better success rate though the risk of amplified side effects is commonplace. However, recent groundbreaking immune therapy combination with the作者: 外星人 時(shí)間: 2025-3-24 13:18 作者: 大吃大喝 時(shí)間: 2025-3-24 16:43 作者: hurricane 時(shí)間: 2025-3-24 22:18 作者: 小歌劇 時(shí)間: 2025-3-24 23:57
Gewalt gegen die Afroamerikanerapeutic agents. Likewise, mitochondria’s involvement in drug resistance is multifaceted, encompassing alterations in energy production, reactive oxygen species (ROS) generation, and apoptotic signaling. Mitochondrial dysfunction can confer resistance to apoptosis-inducing drugs, allowing cancer cell作者: Mitigate 時(shí)間: 2025-3-25 07:11 作者: Jacket 時(shí)間: 2025-3-25 10:00 作者: SEMI 時(shí)間: 2025-3-25 12:05
Drug Resistance in Cancer: Mechanisms and Strategies978-981-97-1666-1作者: Incisor 時(shí)間: 2025-3-25 17:53
enge by employing combinatorial therapies that can prove to be useful and effective. Overall the book reflects on the current treatment challenges, futuristic strategies and new research initiatives that explore novel treatment options..978-981-97-1668-5978-981-97-1666-1作者: chalice 時(shí)間: 2025-3-25 20:08
Introduction to Drug Resistance in Cancer,g drugs, novel strategic options with better efficacy need to be explored that overcome resistance. Combination therapy is a widely used alternative with a better success rate though the risk of amplified side effects is commonplace. However, recent groundbreaking immune therapy combination with the作者: mechanism 時(shí)間: 2025-3-26 02:25 作者: Phonophobia 時(shí)間: 2025-3-26 07:26
Tumor Microenvironment: Multiway Role in Drug Resistance,ys, cellular cross talk, and microenvironmental factors, and the chapter highlights the contribution of TME-driven adaptive strategies such as immune evasion, epithelial-mesenchymal transition, and angiogenesis to therapeutic resistance. It also highlights specific facets including the role of cance作者: Lacunar-Stroke 時(shí)間: 2025-3-26 10:37 作者: 豐富 時(shí)間: 2025-3-26 15:11
Intracellular Compartments and Drug Resistance,apeutic agents. Likewise, mitochondria’s involvement in drug resistance is multifaceted, encompassing alterations in energy production, reactive oxygen species (ROS) generation, and apoptotic signaling. Mitochondrial dysfunction can confer resistance to apoptosis-inducing drugs, allowing cancer cell作者: Neonatal 時(shí)間: 2025-3-26 18:55 作者: 考得 時(shí)間: 2025-3-26 22:15 作者: 聚集 時(shí)間: 2025-3-27 05:03
Mechanisms of Cancer Resistance to Various Therapies,urvival. This chapter provides an overview of current cancer therapies, encompassing radiation therapy, chemotherapy, targeted therapy, immunotherapy, and emerging therapeutic modalities such as viral and gene therapy. This chapter explores the intricate molecular mechanisms underpinning resistance 作者: 發(fā)電機(jī) 時(shí)間: 2025-3-27 07:16 作者: aptitude 時(shí)間: 2025-3-27 10:07
Immune Cells: Critical Players in Drug Resistance,onment (TME), encompassing B cells, effector and regulatory T cells, tumor-associated macrophages (TAMs), myeloid-derived suppressor cells (MDSCs), and tumor-associated neutrophils (TANs), plays a decisive role in tumorigenesis. Various studies showed that MDSCs can create immunosuppressive microenv作者: CULP 時(shí)間: 2025-3-27 16:19
Tumor Microenvironment: Multiway Role in Drug Resistance,rious cellular and noncellular components that cross talk with each other and with the tumor cells, thus supporting tumor progression. The intricate interplay between tumor cells and their surrounding microenvironment has emerged as a pivotal factor influencing the development of drug resistance in 作者: Esophagus 時(shí)間: 2025-3-27 19:02 作者: BILL 時(shí)間: 2025-3-28 02:01
Epigenetic Alterations as an Adaptive Response to Chemotherapy,esponse to chemotherapy. A heritable alteration in gene expression that is unrelated to variations in the sequence of nucleotides is known as epigenetic regulation. Histone modification, noncoding RNA regulation, and DNA methylation have all been thoroughly investigated as common epigenetic regulato作者: mortuary 時(shí)間: 2025-3-28 05:51
Intracellular Compartments and Drug Resistance, synthesis, energy production, and waste disposal. The intricate organization of these compartments creates distinct microenvironments that impact cellular responses to external stimuli, including drug exposure. Understanding the interplay between intracellular compartments and drug resistance is cr作者: Dna262 時(shí)間: 2025-3-28 09:31 作者: pacific 時(shí)間: 2025-3-28 13:23 作者: 棲息地 時(shí)間: 2025-3-28 17:28
Future Directions and Challenges in Overcoming Drug Resistance in Cancer,iomarkers for the development of effective drugs and the integration of artificial intelligence (AI) and machine learning (ML) in drug development. The identification and validation of biomarkers play a pivotal role in tailoring targeted therapies and enhancing treatment efficacy by addressing drug 作者: nugatory 時(shí)間: 2025-3-28 19:33
Book 2024ion to that the book has also discussed novel strategies to overcome the therapeutic challenge by employing combinatorial therapies that can prove to be useful and effective. Overall the book reflects on the current treatment challenges, futuristic strategies and new research initiatives that explore novel treatment options..作者: semble 時(shí)間: 2025-3-29 02:30 作者: Constrain 時(shí)間: 2025-3-29 03:46
,Erg?nzungen für Ausnahmef?lle,them from typical cancer cells. The chapter examines recent advancements in targeting CSCs to overcome drug resistance, emphasizing the importance of developing novel therapeutic approaches that specifically address the unique biology of CSCs.作者: 史前 時(shí)間: 2025-3-29 07:56
Sofortiger Vollzug und Bekanntmachunglate cancer cell metabolism as a promising avenue for overcoming drug resistance. This comprehensive examination not only elucidates the complex link between metabolic reprogramming and drug resistance but also suggests potential therapeutic interventions, presenting a roadmap for future research in the evolving landscape of cancer treatment.作者: 卜聞 時(shí)間: 2025-3-29 11:26
Die USA als Traumland für Migrantenynthesizing these two cutting-edge approaches, this chapter presents an integrative view of how nanoparticle drug delivery and CRISPR-based strategies can synergistically address drug resistance challenges in cancer therapy.作者: glacial 時(shí)間: 2025-3-29 17:17
Mechanisms of Cancer Resistance to Various Therapies,y collaboration are essential for further refining and optimizing cancer therapies, leading to improved outcomes and patient quality of life. Understanding resistance mechanisms and developing innovative therapeutic strategies are crucial for enhancing patient outcomes, making ongoing research and clinical trials indispensable.
